Cambridge Isotope Laboratories
United States Updated 9 July 2026
Cambridge Isotope Laboratories is a contract manufacturer based in United States. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 29 January 2026 as NAI.
2
registered plants
2 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 29 January 2026 NAI US FDA
- 30 August 2022 VAI US FDA
- 9 December 2020 VAI US FDA
- 1 May 2017 VAI US FDA
- 25 March 2016 VAI US FDA
- 7 January 2015 VAI US FDA
- 20 March 2014 VAI US FDA
- 22 August 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Andover, United States | 1000513287 |
| Tewksbury, United States | 3010827078 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Cambridge Isotope Laboratories comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 29 January 2026.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates